Tata Laksana Kraniofaringioma Anak
DOI:
https://doi.org/10.55175/cdk.v51i3.904Keywords:
Pituitary gland, craniopharyngioma, neuroepithelialAbstract
Craniopharyngioma is a benign neuroepithelial tumor around the pituitary gland. Two types of craniopharyngioma based on their morphology are the more common adamantinomatous type (ACP) and the papillary type (PCP). The most common symptoms at diagnosis are hypothalamic/pituitary deficiency, visual disturbances, and increased intracranial pressure. The goal of surgery, whether total or subtotal resection, is decompression of the optic tract and ventricle. Radiotherapy after subtotal resection gives better results; it can be done in children >3 years old, but in practice, it is more often done in children >5 years old. Management of craniopharyngioma requires a multidisciplinary approach.
Downloads
References
Muller HL, Otte A. Childhood-onset craniopharyngioma. J Clin Endocrinol Metabolism. 2021;106(10):3820-36.
Serbis A, Tsinopoulou VR, Papadopoulou A, Kolanis S, Sakellari EI, Margaritis K, et al. Predictive factors for pediatric craniopharyngioma recurrence: An extensive narrative review. Diagnostics 2023;13(9):1588.
Muller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nature Rev. 2019;5:75.
Torres MO, Shafiq I, Mesfin FB. Pediatric craniopharyngioma. National Library of Medicine [Internet]. 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519027/.
Drapeau A, Walz PC, Eide JG, Rugino AJ, Shaikhouni A, Mohyeldin A, et al. Pediatric craniopharyngioma. Child’s Nervous System 2019;35:2133-45.
Diaz MJ, Kwak SH, Root KT, Fadil A, Nguyen A, Ladehoff L, et al. Current approaches to craniopharyngioma management. Front. Biosci. 2022;27 (12):328.
Lithgow K, Hamblin R, Karavitaki N. Craniopharyngiomas. National Library of Medicine [Internet]. 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538819/.
Greenberg MS. Handbook of neurosurgery. 9th Ed. New York: Thieme; 2020.
Krisht KM, Gottfried ON, Couldwell WT. Craniopharyngioma. In: Bernstein M, Berger MS, editors. Neuro-oncology the essential. 3rd Ed. New York: Thieme; 2015 .p. 418-28.
Lee IH, Zan E, Bell WR, Burger PC, Sung H, Yousem DM. Craniopharyngiomas: Radiological differentiation of two types. J Korean Neurosurg. 2016;59(5):466-70.
Huang CC, Lin KL, Wu CT, Jung SM, Wang CJ, Chen YC, et al. Clinical and endocrinological manifestations of childhood-onset craniopharyngioma before surgical removal: A report from one medical center in Taiwan. Pediatr Neonatol. 2021;62(2):181-6
Muller HL. The diagnosis and treatment of craniopharyngiomas. Neuroendocrinol. 2020;110:753–66.
Frühwald MC, Rutkowski S. Tumors of the central nervous system in children and adolescents. Dtsch Arztebl Int. 2011;108(22):390-7.
Zhou Z, Zhang S, Hu F. Endocrine disorder in patients with craniopharyngioma. Front Neurol. 2021;12:737743
Hendricks BK. The neurosurgical atlas [Internet]. 2022. Available from: https://www.neurosurgicalatlas.com/volumes/cranial-base-surgery/other-skull-base-tumors/craniopharyngioma-transcranial-approach.
Ravindra VM, Okcu MF, Ruggieri L, Frank TS, Paulino AC, McGovern SL , et al. Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma long-term analysis of progression-free survival and morbidity. J Neurosurg Pediatr. 2021;28(2):152-9
Alkhalidi H, Hawkins CE. Histopathological features of common pediatric brain tumors. In: Mehta MP, editor. Principles and practice of neuro-oncology: A multidisciplinary approach. New York: Demos Medical; 2011 .p. 213.
Alotaibi NM, Noormohamed N, Cote DJ, Alharthi S, Doucette J, Zaidi HA, et al. Physiologic growth hormone-replacement therapy and craniopharyngioma recurrence in pediatric patients: A meta-analysis. World Neurosurg. 2017;09:165.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Srisabrina Christia, Nurul Hidaya
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
